SCHEMBL14818917

SCHEMBL14818917

NC(CO)(CCCCc1ccc(O)cc1)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 2/20 0.49
ARG2 P78540 2/20 0.49
BLM P54132 1/20 0.45
ESR1 P03372 2/20 0.42
ADRA2A P08913 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
TACR2 P21452 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
SHBG P04278 1/20 0.42
TP53 P04637 1/20 0.42
CYP3A4 P08684 1/20 0.42
HSPD1 P10809 1/20 0.42
ADRB3 P13945 1/20 0.42
HTR2C P28335 1/20 0.42
HSPE1 P61604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2622478 0.86 ARG1 (0.47) ARG1ARG2TNNC1S1PR1SGPL1
SCHEMBL14145263 0.82 ALOX5 (0.47) ARG1ARG2ALDH1A1IGF1RALOX15
SCHEMBL13932736 0.79 S1PR1 (0.66) ALDH1A1TNNC1S1PR1SGPL1S1PR4
SCHEMBL3117439 0.78 BLM (0.61) ARG1ARG2BLMESR1KDM4E
SCHEMBL10778604 0.78 BLM (0.61) ARG1ARG2BLMESR1KDM4E
SCHEMBL3117431 0.78 BLM (0.61) ARG1ARG2BLMESR1KDM4E
SCHEMBL13953044 0.78 ALOX5 (0.48) ALDH1A1
SCHEMBL2632241 0.76 S1PR1 (0.61) ALDH1A1LMNATP53CYP3A4TNNC1
SCHEMBL14499316 0.75 GRM2 (0.50) ARG1ARG2SLC6A3KDM4EALDH1A1
SCHEMBL22033166 0.74 BLM (0.47) BLMESR1ADRA2ASLC6A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2581081-A2 Treatment of viral infections by modulation of host cell metabolic pathways THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-04-17 EP disclosed
EP-2572712-A2 Treatment of viral infections by modulation of host cell metabolic pathways THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2013-03-27 EP disclosed